Chinese scientists, with the aim of enhancing leukemia treatment, have developed a kind of "double-sided tape" that helps the ...

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

A handful of small, early-stage clinical trials are investigating whether CAR-T therapy can improve symptoms in multiple ...

I recently found out that my aunt was diagnosed with cancer and may need chemotherapy. When I think of chemotherapy, I ...

Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

When veterinary chemotherapy failed to stop Rosie – his rescue dog – from succumbing to aggressive mast cell cancer, Paul ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...

The MarketWatch News Department was not involved in the creation of this content. Strategy May Bolster Blood Cancer Therapy and Move HIV Research Closer to a Cure BRONX, N.Y., March 13, 2026 ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.

Researchers in upstate New York are hopeful the work they’re doing may soon lead to new therapies for more cancer ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...